Park W - Search Results

1

A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.

Zhang H, Yun S, Batuwangala TD, Steward M, Holmes SD, Pan L, Tighiouart M, Shin HJ, Koenig L, Park W, Rycroft D, Nannapaneni S, Wang Y, Chen ZG, Shin DM. Zhang H, et al. Among authors: park w. Int J Cancer. 2012 Aug 15;131(4):956-69. doi: 10.1002/ijc.26427. Epub 2011 Nov 19. Int J Cancer. 2012. PMID: 21918971

2

New perspectives of curcumin in cancer prevention.

Park W, Amin AR, Chen ZG, Shin DM. Park W, et al. Cancer Prev Res (Phila). 2013 May;6(5):387-400. doi: 10.1158/1940-6207.CAPR-12-0410. Epub 2013 Mar 6. Cancer Prev Res (Phila). 2013. PMID: 23466484 Free PMC article. Review.

3

Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3.

Nagaraju GP, Park W, Wen J, Mahaseth H, Landry J, Farris AB, Willingham F, Sullivan PS, Proia DA, El-Hariry I, Taliaferro-Smith L, Diaz R, El-Rayes BF. Nagaraju GP, et al. Among authors: park w. Angiogenesis. 2013 Oct;16(4):903-17. doi: 10.1007/s10456-013-9364-7. Epub 2013 Jul 10. Angiogenesis. 2013. PMID: 23838996

4

Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.

Park W, Kwon D, Saravia D, Desai A, Vargas F, El Dinali M, Warsch J, Elias R, Chae YK, Kim DW, Warsch S, Ishkanian A, Ikpeazu C, Mudad R, Lopes G, Jahanzeb M. Park W, et al. Clin Lung Cancer. 2018 May;19(3):280-288.e4. doi: 10.1016/j.cllc.2017.12.007. Epub 2017 Dec 21. Clin Lung Cancer. 2018. PMID: 29336998

5

Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer.

Park W, Lopes G. Park W, et al. Clin Lung Cancer. 2019 May;20(3):143-147. doi: 10.1016/j.cllc.2018.12.003. Epub 2018 Dec 19. Clin Lung Cancer. 2019. PMID: 30683629

6

Biomarker analysis from a phase II multi-institutional study of nivolumab in patients with advanced refractory biliary tract cancer.

Kim DW, Kim YC, Kovari BP, Chung V, Alese OB, El-Rayes BF, Li D, Park W, Kim RD. Kim DW, et al. Among authors: park w. Eur J Cancer. 2022 Nov;176:171-180. doi: 10.1016/j.ejca.2022.09.014. Epub 2022 Sep 28. Eur J Cancer. 2022. PMID: 36252287 Clinical Trial.

7

Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma.

McIntyre CA, Lawrence SA, Richards AL, Chou JF, Wong W, Capanu M, Berger MF, Donoghue MTA, Yu KH, Varghese AM, Kelsen DP, Park W, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Iacobuzio-Donahue CA, Allen PJ, O'Reilly EM. McIntyre CA, et al. Among authors: park w. Cancer. 2020 Sep 1;126(17):3939-3949. doi: 10.1002/cncr.33038. Epub 2020 Jun 23. Cancer. 2020. PMID: 32573775 Free PMC article.

8

Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.

Nagaraju GP, Long TE, Park W, Landry JC, Taliaferro-Smith L, Farris AB, Diaz R, El-Rayes BF. Nagaraju GP, et al. Among authors: park w. Mol Carcinog. 2015 Oct;54(10):1147-58. doi: 10.1002/mc.22185. Epub 2014 May 27. Mol Carcinog. 2015. PMID: 24861206

9

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Naqash AR, Ricciuti B, Owen DH, Florou V, Toi Y, Cherry C, Hafiz M, De Giglio A, Muzaffar M, Patel SH, Sugawara S, Burkart J, Park W, Chiari R, Sugisaka J, Otterson GA, de Lima Lopes G, Walker PR. Naqash AR, et al. Among authors: park w. Cancer Immunol Immunother. 2020 Jul;69(7):1177-1187. doi: 10.1007/s00262-020-02536-5. Epub 2020 Mar 5. Cancer Immunol Immunother. 2020. PMID: 32140762 Free PMC article.

10

Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection.

Husnain M, Park W, Ramos JC, Johnson TE, Chan J, Dasari A, Mudad R, Hosein PJ. Husnain M, et al. Among authors: park w. J Immunother Cancer. 2018 Jul 9;6(1):66. doi: 10.1186/s40425-018-0379-x. J Immunother Cancer. 2018. PMID: 29986769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,775 results

Search Page